Pang L, Lazar D F, Moller D E, Flier J S, Saltiel A R
Department of Physiology, University of Michigan, School of Medicine, Ann Arbor 48109.
Biochem Biophys Res Commun. 1993 Oct 15;196(1):301-10. doi: 10.1006/bbrc.1993.2249.
Naturally occurring human insulin receptor mutants Ser1200 and Thr1134, and a site-directed mutant Arg1030 overexpressed in Chinese hamster ovary (CHO) cells, bind insulin with affinities identical to wildtype receptors but are apparently kinase deficient. Cells expressing the Ser1200 receptor exhibit insulin stimulation of glycogen synthesis similar to these bearing the wildtype receptor, but fail to mediate insulin-responsive DNA synthesis. In contrast, the Thr1134 and Arg1030 mutants exhibit no response to insulin. The activity of Mitogen Activated Protein (MAP) kinase in cells transfected with wildtype receptor is more responsive to insulin than that detected in untransfected parental cells, while cells bearing any of the mutant receptors are less responsive than the parental cells. These differences in the stimulation of MAP kinase activity are paralleled by differences in insulin-dependent phosphorylation of the enzyme. These results suggest that the p42 MAP kinase is not universally required for the metabolic effects of insulin.
天然存在的人类胰岛素受体突变体Ser1200和Thr1134,以及在中国仓鼠卵巢(CHO)细胞中过表达的定点突变体Arg1030,与胰岛素结合的亲和力与野生型受体相同,但显然缺乏激酶活性。表达Ser1200受体的细胞对胰岛素刺激糖原合成的反应与表达野生型受体的细胞相似,但无法介导胰岛素反应性DNA合成。相比之下,Thr1134和Arg1030突变体对胰岛素无反应。转染野生型受体的细胞中丝裂原活化蛋白(MAP)激酶的活性比未转染的亲本细胞对胰岛素更敏感,而携带任何一种突变受体的细胞比亲本细胞的反应性更低。MAP激酶活性刺激的这些差异与该酶的胰岛素依赖性磷酸化差异平行。这些结果表明,p42 MAP激酶并非胰岛素代谢效应普遍必需的。